DTRA glossary aims to promote adoption of decentralized format

By Jenni Spinner

- Last updated on GMT

(TarikVision/iStock via Getty Images Plus)
(TarikVision/iStock via Getty Images Plus)

Related tags Decentralized trials Decentralized Trials and Research Alliance Virtual clinical trials Patient centricity Clinical trials

The Decentralized Trials and Research Alliance is offering the research resource to increase awareness, understanding, and acceptance of the study format.

The Decentralized Trials & Research Alliance (DTRA) has announced the release of its DTRA Glossary, an informational resource emerging from cross-industry collaborative efforts aimed at promoting the global adoption of decentralized research. The glossary can be downloaded by anyone in the worldwide research community (and any other relevant stakeholders) at www.dtra.org​.

According to the organization, the glossary is intended to address two significant challenges:

  • a lack of consistent terminology for use within and between organizations
  • the need for a lexicon to describe different archetypes of decentralized research.

The glossary includes an interactive feedback collection tool to receive updates on existing terms while also identifying potential new terms.

The DTRA Glossary is reportedly the first output from DTRA’s 12 initiatives spanning four priorities as developed by the DTRA Leadership Council. The Glossary Team was co-led by Jared Klingeisen and Alison Poole with program management by Alexa Christensen. Information on the other initiatives can be found at www.dtra.org.

Amir Kalali, DTRA co-founder and co-chairman, said, “The release of the DTRA Glossary marks an important milestone in enabling understanding and uptake of methodologies that will improve access to research for patients. It is a testament of the collaboration of member organizations and will be where the whole community will look to for consistent terminology.”

Craig Lipset, co-founder and co-chairman of DTRA, said, “It is impossible to make progress when there is a Tower of Babel and we are not able to understand one another. This work builds up from the work of other important collaborations and projects, as referenced within the Glossary. This is just the first of a portfolio of new solutions coming forward from the DTRA initiative teams.”

Related news

Related products

show more

How a Clinical MDR Helps with Data Quality

How a Clinical MDR Helps with Data Quality

Formedix | 16-Jan-2023 | Technical / White Paper

This article covers the many ways a clinical metadata repository helps with data quality in the clinical trial process, and how it ultimately helps to...

Optimizing Adherence in DCTs

Optimizing Adherence in DCTs

PPD - Decentralized Clinical Trials | 12-Jan-2023 | Technical / White Paper

Prioritizing greater patient-centricity and creating an opportunity to reach unprecedented patient groups, decentralized and hybrid clinical trials are...

PPD is Supporting Complex EU DCTs

PPD is Supporting Complex EU DCTs

PPD - Decentralized Clinical Trials | 05-Jan-2023 | Technical / White Paper

PPD supports European DCTs and clinical trial sponsors with a holistic and comprehensive approach

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 14-Dec-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us


View more